Search Results - "Donato, Bonnie"
-
1
Methods of sample size calculation in descriptive retrospective burden of illness studies
Published in BMC medical research methodology (09-01-2019)“…Observational burden of illness studies are used in pharmacoepidemiology to address a variety of objectives, including contextualizing the current treatment…”
Get full text
Journal Article -
2
Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome
Published in PharmacoEconomics (01-03-2020)“…Background Atypical haemolytic uraemic syndrome (aHUS) is a rare, potentially life-threatening condition caused by dysregulation of the complement pathway…”
Get full text
Journal Article -
3
Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study
Published in International journal of chronic obstructive pulmonary disease (01-01-2022)“…Patients with chronic obstructive pulmonary disease (COPD) can have low peak inspiratory flow (PIF), especially after hospitalization for acute exacerbation of…”
Get full text
Journal Article -
4
Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review
Published in Orphanet journal of rare diseases (25-04-2019)“…Hypophosphatasia (HPP) is a rare, inherited, metabolic disease caused by tissue-nonspecific alkaline phosphatase deficiency, characterized by bone…”
Get full text
Journal Article -
5
Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer
Published in Urologic oncology (01-05-2011)“…Abstract Objectives Examine the association between clinical, demographic, and socioeconomic factors and the receipt of systemic chemotherapy for bladder…”
Get full text
Journal Article -
6
Impact of Caring for Individuals With Heart Failure in the United States: A Systematic Literature Review
Published in The Journal of cardiovascular nursing (01-03-2024)“…Given the functional impairments and complex care routines associated with heart failure (HF), patients often rely on the support of informal caregivers…”
Get full text
Journal Article -
7
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
Published in JAMA cardiology (01-11-2023)“…Individually, cardiac, renal, and metabolic (CRM) conditions are common and leading causes of death, disability, and health care-associated costs. However, the…”
Get more information
Journal Article -
8
103-LB: Impact of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in COVID-19 Patients with Preexisting Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD)
Published in Diabetes (New York, N.Y.) (20-06-2023)“…Objective: CVD is the leading cause of death and disability among individuals with T2D. National guidelines recommend an SGLT2i or GLP-1 RA in patients with…”
Get full text
Journal Article -
9
809-P: The Impact of High-Deductible Health Plans (HDHPS) and Out-of-Pocket (OOP) Costs on Access to Care in Diabetes
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Background: HDHP use and high OOP costs are associated with decreased healthcare resource use (HCRU) and access to care, among those with lower incomes, or…”
Get full text
Journal Article -
10
Treatment patterns in patients with newly diagnosed COPD in the USA
Published in BMC pulmonary medicine (17-08-2024)“…Prompt and effective management with maintenance therapy (single or dual bronchodilator therapy) is recommended after the initial diagnosis of chronic…”
Get full text
Journal Article -
11
163-LB: Impact of Preexisting Type 2 Diabetes (T2D) and Concurrent Cardiovascular Disease (CVD) on Patients with COVID-19 (C-19)
Published in Diabetes (New York, N.Y.) (01-06-2022)“…Objective: The association of T2D and severe C-19 outcomes has been reported, but data are scarce on whether pre-existing CVD impacts C-19 outcomes in T2D…”
Get full text
Journal Article -
12
Real-world impact of empagliflozin on total cost of care in adults with type 2 diabetes: Results from an outcomes-based agreement
Published in Journal of managed care & specialty pharmacy (01-02-2023)“…Value-based health care is expanding through payment models such as outcomes-based agreements between manufacturers and payers. To describe the…”
Get full text
Journal Article -
13
Persistent Steroid Exposure Before Coronavirus Disease 2019 Diagnosis and Risk of Hospitalization in Patients With Chronic Obstructive Pulmonary Disease
Published in Chronic obstructive pulmonary diseases (01-01-2023)“…It is unclear whether persistent inhaled steroid exposure in chronic obstructive pulmonary disease (COPD) patients before coronavirus disease 2019 (COVID-19)…”
Get full text
Journal Article -
14
Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ © )
Published in Patient preference and adherence (01-01-2020)“…To develop a patient preference questionnaire (PPQ) assessing eculizumab and ravulizumab treatment for paroxysmal nocturnal hemoglobinuria (PNH). The…”
Get full text
Journal Article -
15
Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: A descriptive report
Published in Clinical therapeutics (01-03-2010)“…Abstract Objective: The aim of this work was to analyze chemotherapy treatment patterns in patients with advanced breast cancer who had been previously exposed…”
Get full text
Journal Article -
16
Chemotherapy Use, Outcomes, and Costs for Older Persons With Advanced Non–Small-Cell Lung Cancer: Evidence From Surveillance, Epidemiology and End Results–Medicare
Published in Journal of clinical oncology (15-12-2004)“…There is limited published documentation regarding US community patterns of care for older patients with advanced non-small-cell lung cancer (NSCLC). Using the…”
Get full text
Journal Article -
17
Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19
Published in Journal of health economics and outcomes research (Online) (2024)“…The economic burden associated with type 2 diabetes mellitus (T2DM) and concurrent cardiovascular disease (CVD) among patients with COVID-19 is unclear. We…”
Get full text
Journal Article -
18
The epidemiologic burden of hepatitis C virus infection in Latin America
Published in Annals of hepatology (01-09-2012)“…Chronic infection with hepatitis C virus (HCV) is a major and growing public health concern worldwide, including in Latin America. With more efficacious…”
Get full text
Journal Article -
19
Quality of Care for Patients with Type 2 Diabetes Mellitus in Dubai: A HEDIS-Like Assessment
Published in International Journal of Endocrinology (01-01-2015)“…Objective. As little data are available on the quality of type 2 diabetes mellitus (T2DM) care in the Arabian Gulf States, we estimated the proportion of…”
Get full text
Journal Article -
20
Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck
Published in Current medical research and opinion (01-12-2011)“…Abstract Background: Cetuximab (Erbitux* *Erbitux is a registered trade name of Bristol-Myers Squibb, Princeton, NJ, USA.) is the only new medical therapy for…”
Get full text
Journal Article